Related Experiment Video
Updated: Jan 11, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Orchestrating inflammation: non-coding RNAs as master regulators of macrophage function in chronic obstructive
Xinyu Yong1,2, Xian Luo1,2, Xiaobing Chen1,2
1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Non-coding RNAs (ncRNAs) critically regulate macrophage function in chronic obstructive pulmonary disease (COPD). Targeting these ncRNA-macrophage interactions offers promising avenues for personalized COPD diagnostics and therapies.
Area of Science:
- Immunology
- Molecular Biology
- Pulmonary Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue.
- Macrophage dysfunction and chronic inflammation are hallmarks of COPD.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their role in regulating macrophage behavior.
Purpose of the Study:
- To review the current evidence on how ncRNA-macrophage regulatory axes contribute to COPD pathogenesis.
- To explore the diagnostic and therapeutic potential of ncRNAs in COPD.
- To identify challenges and future directions in ncRNA-based COPD research.
Main Methods:
- Comprehensive literature review of studies investigating ncRNAs (miRNAs, lncRNAs, circRNAs) and their impact on macrophage polarization in COPD.
- Analysis of molecular pathways (e.g., NF-κB, STAT3) involved in ncRNA-mediated inflammation.
- Examination of clinical studies translating mechanistic insights into biomarkers and therapeutic targets.
Main Results:
- Pro-inflammatory miRNAs (e.g., miR-155) drive M1 macrophage polarization and inflammation.
- Anti-inflammatory miRNAs promote resolution of inflammation.
- Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) employ complex regulatory mechanisms, including acting as scaffolds and competing for microRNAs.
- ncRNAs have shown potential as diagnostic biomarkers and therapeutic targets in human COPD patients.
Conclusions:
- ncRNA-macrophage regulatory axes are key drivers of COPD progression.
- Targeting these axes presents a promising strategy for developing novel diagnostics and therapeutics for COPD.
- Further research is needed to overcome methodological challenges and fully realize the clinical potential of ncRNA-based precision medicine in COPD management.
More Related Videos
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
MicroRNAs
MicroRNAs
Translational Regulation